HBM Healthcare Investments AG

HBMN

CH0012627250

Investment Management & Fund Operators

Market Closed - Swiss Exchange Other stock markets 11:30:20 2024-06-21 EDT			5-day change	1st Jan Change
207.5 ^CHF	-1.19%		+0.48%	+13.64%

05-28	HBM Healthcare Flags NAV Boost from Yellow Jersey-Johnson & Johnson Deal	MT
05-23	HBM Healthcare Investments' Portfolio Company to Buy Laboratorios Biopas Group	MT

Tranche Update on HBM Healthcare Investments AG's Equity Buyback Plan announced on July 5, 2023.

May 08, 2024 at 12:00 am

From January 1, 2024 to March 31, 2024, the company has repurchased 43,650 shares. With this, the company has completed the repurchase of 89,360 share under the buyback announced on July 5, 2023.

Latest news about HBM Healthcare Investments AG

HBM Healthcare Flags NAV Boost from Yellow Jersey-Johnson & Johnson Deal	05-28	MT
HBM Healthcare Investments' Portfolio Company to Buy Laboratorios Biopas Group	05-23	MT
HBM Healthcare Investments' Net Loss Narrows in FY24	05-09	MT
HBM Healthcare Investments AG Reports Earnings Results for the Full Year Ended March 31, 2024	05-08	CI
Tranche Update on HBM Healthcare Investments AG's Equity Buyback Plan announced on July 5, 2023.	05-08	CI
HBM Healthcare Investments Warns of CHF1 Million Loss for FY24	04-03	MT
Tranche Update on HBM Healthcare Investments AG's Equity Buyback Plan announced on July 5, 2023.	01-30	CI
HBM Healthcare Investments AG Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	01-22	CI
HBM Healthcare Investments Logs Lower Fiscal Q3 Loss	01-22	MT
HBM Healthcare Investments Warns of FY24 Nine-month Net Loss	01-04	MT
AbbVie to Buy Cancer-focused ImmunoGen for $10.1 Billion	11-30	MT
Kepler Cheuvreux Lowers Price Target on HBM Healthcare Investments, Maintains Buy Recommendation	11-21	MT
HBM Healthcare Investments Launches Share Buyback	23-10-16	MT
HBM Healthcare Investments AG Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	23-10-16	CI
HBM Healthcare Investments Logs Higher Fiscal H1 Loss	23-10-16	MT
Tranche Update on HBM Healthcare Investments AG's Equity Buyback Plan announced on July 5, 2023.	23-10-16	CI
HBM Healthcare Investments Flags Fiscal H1 Loss	23-10-03	MT
HBM Healthcare Investments AG Reports Earnings Results for the First Quarter Ended June 30, 2023	23-07-21	CI
HBM Healthcare Investments' Ficsal Q1 NAV Per Share Declines	23-07-21	MT
HBM Healthcare Investments AG commences an Equity Buyback Plan under the authorization approved on June 10, 2022.	23-07-05	CI
HBM Healthcare's Portfolio Company Cathay Biotech to Sell Shares for CNY6.6 Billion	23-06-26	MT
Kepler Cheuvreux Lowers Price Target on HBM Healthcare Investments, Maintains Buy Recommendation	23-06-14	MT
HBM Healthcare Investments AG Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-26	CI
HBM Healthcare Investments' Loss Widens in FY23	23-05-12	MT
HBM Healthcare Investments Posts 3% Drop in April NAV	23-05-02	MT

Chart HBM Healthcare Investments AG

Duration

Period

More charts

HBM Healthcare Investments AG is a Switzerland-based venture capital company investing in emerging companies, mainly from the biotechnology and human medicine, diagnostics, as well as medical technology sectors. The Company focuses on unlisted companies, with two-thirds of assets being invested in private companies that offer high value-creation potential. As a holding company, it is involved in the acquisition, disposal and management of a diversified portfolio, as well as in financing and supporting the portfolio firms as a key partner. It focuses on companies with products either at an advanced stage of development or already available on the market. The primary investment areas are Western Europe and the United States. The Company's portfolio includes approximately 25 companies. As of March 31, 2012, the Company had six wholly owned subsidiaries, including three subsidiaries on Cayman Islands, two Barbados-based subsidiaries and a subsidiary in the United States.

Sector

Investment Management & Fund Operators

Calendar

2024-07-18 - Q1 2025 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for HBM Healthcare Investments AG

Trading Rating

Investor Rating

ESG Refinitiv

D+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

207.5 CHF

Average target price

236 CHF

Spread / Average Target

+13.73%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Venture Capital

	1st Jan change	Capi.
HBM HEALTHCARE INVESTMENTS AG	+13.64%	1.59B
HERCULES CAPITAL, INC.	+18.90%	3.17B
UMBRA COMPANIES INC.	+12.50%	1.76B
OCTOPUS TITAN VCT PLC	-11.54%	1.22B
MOLTEN VENTURES PLC	+45.71%	960M
CION INVESTMENT CORPORATION	+8.49%	657M
VERUSA HOLDING	+49.75%	629M
OCTOPUS APOLLO VCT PLC	-4.17%	502M
WOORI TECHNOLOGY INVESTMENT CO., LTD	+26.09%	455M
GOZDE GIRISIM SERMAYESI YATIRIM ORTAKLIGI	+35.64%	331M

Venture Capital

HBM Healthcare Investments AG

Equities

HBMN

CH0012627250

Investment Management & Fund Operators

Tranche Update on HBM Healthcare Investments AG's Equity Buyback Plan announced on July 5, 2023.

Latest news about HBM Healthcare Investments AG

Chart HBM Healthcare Investments AG

Company Profile

Income Statement Evolution

Ratings for HBM Healthcare Investments AG

Analysts' Consensus

EPS Revisions

Annual profits - Rate of surprise

Sector Venture Capital